
I shed more than 3st on Mounjaro – I love my new body but wasn't prepared for my hair to fall out in clumps
HAIR ME OUT I shed more than 3st on Mounjaro – I love my new body but wasn't prepared for my hair to fall out in clumps
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
AFTER dropping more than 3 stone in less than seven months, Nour Mansour was thrilled by the effects of Mounjaro.
The 28-year-old mum had struggled with her weight since the birth of her twin daughters, now four, and was chuffed with the confidence boost.
Sign up for Scottish Sun
newsletter
Sign up
2
Her hair, once full and falling nearly to her hips, began shedding at a rate that was alarming
Credit: TIKTOK/@nour.manso
2
Many women have reported hair thinning or shedding as a side effect of rapid weight loss
Credit: TIKTOK/@nour.manso
But six months into the journey, Nour noticed a disturbing side effect.
Her hair, which was once full and falling nearly to her hips, began shedding at a rate that was alarming.
''I'd run my hands through my hair and clumps would fall out,'' the administration assistant told Mail Online.
The mum-of-two was horrified when she realised her once-long tresses went from ''glossy and thick to dry and frizzy''.
The temples, she shared, were also thinning, and to cover it up Nour was wearing caps and headbands all the time.
Many women have reported hair thinning or shedding as a side effect of rapid weight loss or hormonal changes on medications such as Mounjaro.
However, experts believe the medication does not cause the problem.
Dr David Fenton, consultant dermatologist at OneWelbeck and a world-renowned hair loss specialist, told the publication: ''Rapid weight loss or sudden dietary changes can leave people deficient in the nutrients essential for healthy hair growth.
''These include iron, vitamin B12, folate, zinc and vitamin D. When users lose their appetite and start eating less, they risk missing out on key vitamins.''
A lack of protein can also be a factor, the expert warned, as hair is primarily made from keratin – a tough, fibrous protein that is a key structural component of hair, nails, and the outer layer of skin.
I lost 6st on Mounjaro but hate my body even more - I feel disgusting
Without enough, the tresses start to become weak and brittle.
There have also been other side effects seen in GLP-1 users - brittle fingernails and slowed nail growth - both of which have been linked to these deficiencies.
Dr David Strain, a diabetes expert at Exeter Medical School, explained that during trials, closely-monitored participants are kept on a nutrient-rich diet.
However, in the real world, many simply don't know how to meet their nutritional needs or what supplements they might require for good health.
Dr Fenton advised that if you're concerned about hair loss you should consider a blood test, particularly if you're vegan and vegetarian.
Hair Loss 101
HAIR pro Samantha Cusick has revealed everything you need to know about hair loss.
Why Does Hair Loss Happen?
Hair loss can be influenced by so many factors, from genetics and hormone changes to lifestyle choices.
Stress, diet, and even hair care habits can all impact hair strength.
It's perfectly normal to lose some hair each day, but sometimes the body can shed more than usual, responding to things like hormonal shifts or even life stressors.
Why It Happens More This Time of Year
Have you ever noticed your hair seems to shed more in autumn? That's seasonal shedding!
During summer, we hold onto extra hair to protect our scalp from the sun.
As the weather cools, it's like our body recalibrates and lets go of those extra strands.
Dry, cooler air can also make hair more brittle, making it easier to lose a little extra volume during these months.
Hacks and Affordable Buys to Treat Hair loss
The great news? You don't need to spend a fortune on pricey treatments to support your hair.
Try daily scalp massages—they're so simple but really help boost blood flow to the follicles.
Castor oil is another fantastic, budget-friendly option that's rich in nutrients to strengthen your strands.
Adding a bit more protein to your diet and a biotin supplement can also work wonders for overall hair health.
Products to Avoid
Steer clear of products with high levels of alcohol, sulphates, and parabens - they can be drying and damage hair over time.
Heat styling and chemical treatments can also cause breakage, so try to use them sparingly.
Instead, look for gentle, hydrating formulas to support your scalp and keep hair healthier through the seasons.
If you want to boost your iron, it's worth upping your intake of red meat, dark leafy greens, such as kale and spinach, nuts and seafood.
Meanwhile, dairy, such as yoghurt and kefir, eggs and wholegrains are good sources of zinc.
B12 - which is primarily found in animal products - is widely available in supplement form.
Normally, Dr Fenton said, about 90 per cent of the hair follicles are growing and 10 per cent are resting.
However, when the body is under stress, whether that's from illness or significant weight loss, that cycle changes and a higher percentage of follicles go into the shedding phase.
''The more weight you lose, and the faster you lose it, the higher the risk.''
Similar to postpartum hair loss in women, this condition is known as telogen effluvium and the issue usually resolves itself over time.
Luckily, there are, however, steps that can help to minimise damage.
Slowing down weight loss can also help, as it reduces the stress on the body.
Nour - who posts under the username @nour.manso - had a similar turnaround.
After speaking to her GP, the mum began taking supplements and focused on eating well – and the shedding stopped.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Evening Standard
an hour ago
- Evening Standard
Disadvantaged white pupils have ‘particularly poor' education outcomes
Can these secret ingredients really have the same effect on weight loss as Ozempic and Mounjaro? Can asparagus, apples and eggs really mimic the effects of Ozempic?

Western Telegraph
2 hours ago
- Western Telegraph
Type 2 diabetes patients set for major shake-up in care
The health service should move from a one-size-fits-all approach of starting everyone on the same medication, to more personalised care that aims to prevent complications like heart failure and heart attacks, according to new draft guidance from the National Institute for Health and Care Excellence (Nice). This includes making newer type 2 diabetes drugs, known as SGLT-2 inhibitors, a first-line treatment option in a move that could eventually help save tens of thousands of lives. SGLT-2 inhibitors, which include canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, are once-a-day tablets that reduce blood sugar levels by helping the kidneys remove glucose, which is passed from the body through urine. However, analysis by Nice found these drugs are under-prescribed. The new guidelines recommend patients who cannot tolerate metformin – the first-choice in type 2 diabetes medication – should start with an SGLT-2 inhibitor on its own. The decision comes after evidence suggested these drugs protect the heart and kidneys as well as controlling blood sugar, Nice said. It is estimated the change could save almost 22,000 lives once uptake reaches 90% of the population. Nice also suggests some groups of patients would also benefit from GLP-1 receptor agonists such as liraglutide or semaglutide sooner, rather than keeping them for the later stages of treatment. Semaglutide, sold under the brand name Ozempic, is licensed in the UK to treat type 2 diabetes, while its other brand – Wegovy – is also used by the NHS to help obese people lose weight. Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice, said: 'This guidance means more people will be offered medicines where it is right to do so to reduce their future risk of ill health. 'This represents a significant evolution in how we approach type 2 diabetes treatment. 'We're moving beyond simply managing blood sugar to taking a holistic view of a person's health, particularly their cardiovascular and kidney health. 'The evidence shows that certain medicines can provide important cardiovascular benefits, and by recommending them as part of initial treatment, we could help prevent heart attacks, strokes and other serious complications before they occur. 'This is particularly important given that cardiovascular disease is the leading cause of death in people with type 2 diabetes.' Around 4.6 million people in the UK are living with diabetes, with nine in 10 of those having type 2. However, it is estimated that a further 1.3 million people may have undiagnosed type 2 diabetes. Nice analysed the records of 590,000 people and found SGLT-2 inhibitors are under-prescribed, particularly to women, older people, and black patients. Prof Benger added: 'The evidence from our analysis is clear. There are prescribing gaps that need to be addressed. 'The guideline update published today will help to increase equitable uptake of SGLT-2 inhibitors, which we know can prevent serious health complications.' Dr Waqaar Shah, chairman of the guideline committee, added: 'We know that SGLT-2 inhibitors are currently under-prescribed, and our health economics analysis shows that people living in the most deprived areas would particularly benefit from universal access to these treatments. 'These recommendations could help reduce health inequalities while providing better outcomes for everyone.' Elsewhere, the draft guidance suggests different treatments for diabetes patients with certain characteristics or health conditions. These include adults with cardiovascular disease, who should be offered a triple therapy including a GLP-1 receptor agonist. Meanwhile, adults diagnosed with type 2 diabetes before 40 should be offered dual therapy before a GLP-1 receptor agonist is considered, while patients with chronic kidney disease should have tailored recommendations based on their kidney function. A public consultation on the new Nice guidelines is open until October 2. Douglas Twenefour, head of clinical at Diabetes UK, said: 'This long-awaited announcement propels type 2 diabetes treatment into the 21st century. 'Boosting access to newer treatments will be transformative for people with type 2 diabetes, while ensuring the UK keeps pace with the global momentum in treating the condition. 'The majority of people with type 2 diabetes are not currently taking the most effective medication for them, putting them at risk of devastating diabetes-related complications. 'Diabetes is a leading cause of cardiovascular disease, and tailoring treatment based on individual risk could protect thousands against heart attacks and kidney disease. 'These guidelines could go a long way to easing the burden of living with this relentless condition, as well as helping to address inequities in type 2 diabetes treatments and outcomes.'

Times
6 hours ago
- Times
Mounjaro UK price rise will trigger obesity relapse, say experts
The upcoming Mounjaro price hike could cause people to pile weight back on and 'cycle in and out of obesity', experts have warned. The weight-loss jab, which is bought privately by 1.5 million people in the UK, will more than double in price next month — forcing patients off the drug if they can no longer afford it. Its manufacturer, Eli Lilly, is increasing the list price for the maximum 15mg dose from £122 to £330 for a monthly pen, while the 5mg dose is rising from £92 to £180. Pharmacies have warned that patients are in 'immense distress', with demand soaring as they stock up on Mounjaro before the price increase takes effect on September 1. Professor Tim Spector, a nutrition expert at King's College London, warned that the sudden increase in price had exposed the flaws of relying on weight-loss jabs to lose weight. He said: 'The price rise of the GLP-1 drugs comes at a tricky time for the million-plus Britons that have started taking the drugs. Any losses in weight they will have achieved will be reversed in just a few weeks, as their appetite kicks back in. 'People are being prompted to use these private networks of GLP-1 drugs without any real supervision, and, crucially, without any nutritional support.' Spector, co-founder of the Zoe nutrition app, said that people who were taking weight-loss jabs should instead have been 're-educated about food and good eating habits long term'. He added: 'It's a huge wasted opportunity that's going to get worse as the price for the consumer goes up, and therefore people are unlikely to stay on this long term. We're just going to be back to good old short-term diets, which will cycle people in and out of obesity.' The price hike is taking place after President Trump demanded that pharmaceutical firms lower prices for American patients and stop other countries 'freeloading' off US firms. Pharmacies said they were experiencing record demand and were helping people to switch from Mounjaro to Wegovy, a similar GLP-1 drug known as Ozempic when used for diabetes, as it is cheaper, although not thought to be as effective. • Jon Yeomans: Mounjaro is a taste of the battle to come over drug prices James O'Loan, the chief executive of the online pharmacy Chemist4U, said: 'The distressing news that prices are set to rise by up to 170 per cent with just two weeks' notice, in response to another aggressive initiative from Trump, is very troubling. It's caused immense distress to hundreds of thousands of UK patients on a weight loss journey, who worry all their hard-earned progress could be snatched away from them.' Asda Online Doctor said: 'Following the announcement of steep price increases by the manufacturer Eli Lilly starting in September, we have seen an instant 350 per cent increase in demand. We are making all efforts to enable our existing patients to continue treatment and are actively prioritising them. 'However, this will be a difficult situation for many of our patients with affordability being a key aspect in the access and/or continuation of these services. Therefore we deeply regret this decision from Eli Lilly to increase prices, which will affect many patients. We remain committed to providing an excellent service to our patients at a fair price.' • Mounjaro transformed me — but it had a huge effect on my family's life Dr Leyla Hannbeck, chief executive of the Independent Pharmacies Association, representing thousands of community pharmacies, said: 'Our members up and down the country have been dealing with worried patients, many of whom are enquiring about stocking up before the price increase hits. 'There is a very real danger that the higher prices will see patients desperate for cheaper products turn to the, often unregulated, online market.' Sandeep Dhami, a superintendent pharmacist at MW Phillips Chemists in the West Midlands, added: 'Patients on their weight-loss journeys are coming into pharmacies like mine angry and upset at the news of the price hike. Those on the highest doses, who will face the highest price hike are particularly concerned.'



